Shandong Jincheng Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 4/6
Shandong Jincheng Pharmaceutical Group is a dividend paying company with a current yield of 1.51% that is well covered by earnings.
Key information
1.5%
Dividend yield
-0.07%
Buyback Yield
| Total Shareholder Yield | 1.4% |
| Future Dividend Yield | n/a |
| Dividend Growth | 7.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.200 |
| Payout ratio | 59% |
Recent dividend and buyback updates
Recent updates
Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Bounce 39% But Its Business Still Trails The Market
Oct 08
Estimating The Intrinsic Value Of Shandong Jincheng Pharmaceutical Group Co., Ltd (SZSE:300233)
Oct 07Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Popularity With Investors Is Under Threat From Overpricing
Jun 07Shandong Jincheng Pharmaceutical Group's (SZSE:300233) Problems Go Beyond Weak Profit
Apr 04Shandong Jincheng Pharmaceutical Group Co., Ltd's (SZSE:300233) Shares Climb 29% But Its Business Is Yet to Catch Up
Mar 04Shandong Jincheng Pharmaceutical Group (SZSE:300233) Seems To Use Debt Quite Sensibly
Mar 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 300233's dividend payments have been volatile in the past 10 years.
Growing Dividend: 300233's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Shandong Jincheng Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (300233) | 1.5% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (300233) (up to 3 years) | n/a |
Notable Dividend: 300233's dividend (1.51%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 300233's dividend (1.51%) is low compared to the top 25% of dividend payers in the CN market (2.16%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (58.9%), 300233's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (53.4%), 300233's dividend payments are covered by cash flows.